Could a Week-Long heart patch catch more dangerous rhythms than a One-Day test?
NCT ID NCT06310707
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether wearing a small, waterproof heart monitor (ePatch) for 7 days finds more treatable heart rhythm problems than the usual 24-hour Holter monitor in people who have fainted. About 55 adults with fainting symptoms were randomly assigned to either the 7-day ePatch or a standard 24-hour monitor. The goal was to see if the longer monitoring period leads to more diagnoses that can guide treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ePatch Extended Wear Holter (7-day heart monitor)
What this could lead to
If successful, this could show that longer monitoring with ePatch finds more treatable heart rhythm problems than the standard 24-hour test.
What could go wrong
The study was terminated early with only 55 participants, so results may be limited. Longer monitoring may also pick up harmless findings that lead to unnecessary worry or tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYNCOPE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Deutsches Herzzentrum der Charité (DHZC) - Campus Benjamin Franklin
Berlin, D-12203, Germany
-
Hospices Civils de Lyon - Hôpital Cardiologique Louis Pradel
Bron, 69677 Cedex, France